Reply on Clarification sought by the Exchange on Price Movement of the Script of the Company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
BSE's Surveillance Department had sought clarification from Nexus Surgical And Medicare Ltd regarding significant price movement in the company's securities. The company has responded stating the price movement was purely market-driven and not due to any company-specific developments. Nexus Surgical confirmed full compliance with SEBI (LODR) Regulations, 2015 and stated there is no undisclosed or price-sensitive information that needs to be disclosed. The company also stated there are no impending announcements or corporate actions pending at this time. The Managing Director, Ram Swaroop Joshi, signed the response on 13th May, 2026.
The clarification is largely neutral for shareholders. The company has reassured regulators that the recent price surge was not caused by insider information or upcoming corporate actions, which removes a key uncertainty. The stock's movement is attributed to general market dynamics rather than fundamental changes in the company.